Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Zhe, Shi, Lei, Wang, Yijin, Zhang, Jiyuan, Huang, Lei, Zhang, Chao, Liu, Shuhong, Zhao, Peng +10 more·2020·The Lancet Respiratory Medicine

Cited by (1,023)

Items 701–800 of 1,023

  1. Deep learning for predicting COVID-19 malignant progression
    Cong Fang, Song Bai, Qianlan Chen, Yu Zhou, Liming Xia, Lixin Qin, Shi Gong, Xudong Xie, Chunhua Zhou, Dandan Tu et al. · 2021 · Medical Image Analysis
  2. The Role of Th17 Response in COVID-19
    Diana Martonik, Anna Parfieniuk‐Kowerda, Magdalena Rogalska, Robert Flisiak · 2021 · Cells
  3. Coronavirus disinfection in histopathology
    Anthony F. Henwood · 2020 · Journal of Histotechnology
  4. An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases
    Chengzhi Yang, Zening Jin · 2020 · JAMA Cardiology
  5. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
    Carlos Humberto Saavedra Trujillo · 2020 · Infectio
  6. Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan
    Takuya Adachi, Ja‐Mun Chong, Noriko Nakajima, Masahiro Sano, Jun Yamazaki, Ippei Miyamoto, Haruka Nishioka, Hidetaka Akita, Yuko Sato, Michiyo Kataoka et al. · 2020 · Emerging infectious diseases
  7. SARS-CoV-2 and COVID-19: From the Bench to the Bedside
    Stefano Romagnoli, Adriano Peris, Angelo Raffaele De Gaudio, Pierangelo Geppetti · 2020 · Physiological Reviews
  8. Immunity against COVID-19: Potential role of Ayush Kwath
    Shankar Gautam, Arun Gautam, Sahanshila Chhetri, Urza Bhattarai · 2020 · Journal of Ayurveda and Integrative Medicine
  9. The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization
    Michele A. Kohli, Michael Maschio, Debbie L. Becker, Milton C. Weinstein · 2021 · Vaccine
  10. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients
    Changfu Yao, Stephanie A. Bora, Tanyalak Parimon, Tanzira Zaman, Oren Friedman, Joseph Alexander Palatinus, Nirmala S. Surapaneni, Yuri P. Matusov, Giuliana Cerro Chiang, Alexander G. Kassar et al. · 2020 · Cell Reports
  11. COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae
    Leonardo Italia, Daniela Tomasoni, Stefano Bisegna, Edoardo Pancaldi, Lorenzo Stretti, Marianna Adamo, Marco Metra · 2021 · Frontiers in Cardiovascular Medicine
  12. Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies
    Baik, Alan H., Oluwole, Olalekan O., Johnson, Douglas B., Shah, Nina, Salem, Joe-Elie, Tsai, Katy K., Moslehi, Javid J. · 2021 · Circulation Research
  13. Magnetic Particle Spectroscopy: A Short Review of Applications Using Magnetic Nanoparticles
    Kai Wu, Diqing Su, Renata Saha, Jinming Liu, Vinit Kumar Chugh, Jian‐Ping Wang · 2020 · ACS Applied Nano Materials
  14. COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment?
    Marie-Pierrette Ntyonga-Pono · 2020 · Pan African Medical Journal
  15. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
    Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Alexander J. V. Thompson, Jidong Jia, Jinlin Hou, Cosmas Rinaldi Adithya Lesmana, Adityo Susilo, Yasuhito Tanaka, Wah‐Kheong Chan, Ed J. Gane et al. · 2020 · The Lancet. Gastroenterology & hepatology
  16. Significance of geographical factors to the COVID-19 outbreak in India
    Amitesh Gupta, Sreejita Banerjee, Sumit Das · 2020 · Modeling Earth Systems and Environment
  17. A review of the main histopathological findings in coronavirus disease 2019
    Walter O. Vasquez-Bonilla, Roberto Orozco, Víctor Argueta, Manuel Sierra, Lysien I. Zambrano, Fausto Muñoz‐Lara, Dennis Salomon Lopez Molina, Kovy Arteaga‐Livias, Zachary Grimes, Clare Bryce et al. · 2020 · Human Pathology
  18. Repurposing of Kinase Inhibitors for Treatment of COVID-19
    Ellen Weisberg, Alexander Parent, Priscilla L. Yang, Martin Sattler, Qingsong Liu, Qingwang Liu, Jinhua Wang, Chengcheng Meng, Sara J. Buhrlage, Nathanael S. Gray et al. · 2020 · Pharmaceutical Research
  19. Multiple Neuroinvasive Pathways in COVID-19
    Dmitri Bougakov, Kenneth Podell, Elkhonon Goldberg · 2020 · Molecular Neurobiology
  20. Covid-19 Pandemic's Impact on Eating Habits in Saudi Arabia
    Noara Khaled Alhusseini, Abdulrahman Alqahtani · 2020 · Journal of Public Health Research
  21. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications
    Corrado Pelaia, Caterina Tinello, Alessandro Vatrella, Giovambattista De Sarro, Girolamo Pelaia · 2020 · Therapeutic Advances in Respiratory Disease
  22. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage
    Osama Al‐Dalahmah, Kiran Teresa Thakur, Anna Starikovsky Nordvig, Morgan Prust, William Roth, Angela Lignelli, Anne‐Catrin Uhlemann, Emily Happy Miller, Shajo Kunnath-Velayudhan, Armando Del Portillo et al. · 2020 · Acta Neuropathologica Communications
  23. SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts
    Amy L. Hartman, Sham Nambulli, Cynthia M. McMillen, Alexander G. White, Natasha L. Tilston‐Lunel, Joseph R. Albe, Emily L. Cottle, Matthew Dunn, Lonnie James Frye, Theron H. Gilliland et al. · 2020 · PLoS Pathogens
  24. Immune Modulatory Effects of Vitamin D on Viral Infections
    Maheen Siddiqui, Judhell S. Manansala, Hana A. Abdulrahman, Gheyath K. Nasrallah, Maria K. Smatti, Nadin Younes, Asmaa A. Al Thani, Hadi Mohamad Yassine · 2020 · Nutrients
  25. How fear and collectivism influence public’s preventive intention towards COVID-19 infection: a study based on big data from the social media
    Feng Huang, Huimin Ding, Zeyu Liu, Peijing Wu, Meng Zhu, Ang Li, Tingshao Zhu · 2020 · BMC Public Health
  26. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience
    Roberto Littera, Marcello Campagna, Silvia Deidda, Goffredo Angioni, Selene Cipri, Maurizio Melis, Davide Firinu, Simonetta Santus, Alberto Lai, Rita Porcella et al. · 2020 · Frontiers in Immunology
  27. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers
    Letícia Adrielle dos Santos, Pedro Germano de Góis Filho, Ana Maria Fantini Silva, João Victor Gomes dos Santos, Douglas Siqueira Santos, Marília Marques Aquino, Rafaela Mota de Jesus, Maria Luíza Dória Almeida, João S. Silva, Daniel Martin Altmann et al. · 2021 · Journal of Infection
  28. Targeting TNF-α for COVID-19: Recent Advanced and Controversies
    Yi Guo, Ke Hu, Yuxuan Li, Chanjun Lu, Ken Ling, Chuanqi Cai, Weici Wang, Dawei Ye · 2022 · Frontiers in Public Health
  29. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study
    Jonathan Tschopp, Arnaud Grégoire L’Huillier, Matteo Mombelli, Nicolas Johannes Mueller, Nina Khanna, Christian Garzoni, Dario Meloni, Matthaios Papadimitriou‐Olivgeris, Dionysios Neofytos, Hans Hellmuth Hirsch et al. · 2020 · American Journal of Transplantation
  30. Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19)
    Abdul Mannan Baig, Erin C. Sanders · 2020 · Journal of Medical Virology
  31. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID‐19 patients
    Fesih Ok, Ömer Erdoğan, Emrullah Durmuş, Serkan Carkci, Ağgül Canik · 2020 · Journal of Medical Virology
  32. The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019
    Yichun Cheng, Ran Luo, Xu Wang, Kun Wang, Nanhui Zhang, Meng Zhang, Zhixiang Wang, Lei Dong, Junhua Li, Rui Zeng et al. · 2020 · Clinical Journal of the American Society of Nephrology
  33. Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
    Surjeet Verma, Danielle Twilley, Tenille Esmear, Carel B. Oosthuizen, Anna-Mari Reid, Marizé Cuyler, Namrita Lall · 2020 · Frontiers in Pharmacology
  34. Manejo quirúrgico de pacientes con infección por COVID-19. Recomendaciones de la Asociación Española de Cirujanos
    José María Balibrea, Josep María Badía, Ines Rubio Perez, Esteban Martín Antona, Estíbaliz Álvarez Peña, Sandra García Botella, Mario Álvarez Gallego, Elena Martín‐Pérez, Sagrario Martínez Cortijo, Isabel Pascual Miguelañez et al. · 2020 · Cirugía Española
  35. ACE2 and COVID-19 and the resulting ARDS
    Xiaoqing Zhang, Shuren Li, Shaoqian Niu · 2020 · Postgraduate Medical Journal
  36. Reappearance of effector T cells is associated with recovery from COVID-19
    Ivan Odak, Joana Barros‐Martins, Berislav Bošnjak, Klaus Stahl, Sascha David, Olaf Wiesner, Markus Busch, Marius M. Hoeper, Isabell Pink, Tobias Welte et al. · 2020 · EBioMedicine
  37. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection
    Jing Qi, Yang Zhou, Jiao Hua, Liying Zhang, Jialin Bian, Beibei Liu, Zicen Zhao, Shuilin Jin · 2021 · International Journal of Environmental Research and Public Health
  38. Analysis and predictions of spread, recovery, and death caused by COVID-19 in India
    Rajani Kumari, Sandeep Kumar, Ramesh Chandra Poonia, Vijander Singh, Linesh Raja, Vaibhav Bhatnagar, Pankaj K. Agarwal · 2021 · Big Data Mining and Analytics
  39. Lymphopenia Caused by Virus Infections and the Mechanisms Beyond
    Zijing Guo, Zhidong Zhang, Meera Prajapati, Yanmin Li · 2021 · Viruses
  40. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19
    Mattia Bellan, Alessio Baricich, Filippo Patrucco, Patrizia Zeppegno, Carla Maria Gramaglia, Piero Emilio Balbo, Alessandro Carriero, Chiara Santa Amico, Gian Carlo Avanzi, Michela Barini et al. · 2021 · Scientific Reports
  41. Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019
    Rong L. Yin, Wei Feng, Tonghui Wang, Gang Chen, Tina Wu, Dongrui Chen, Tangfeng Lv, Dawei Xiang · 2020 · Journal of Medical Virology
  42. Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal
    Dejan Radovanovic, Maurizio Rizzi, Stefano Pini, Marina Saad, Davide Chiumello, Pierachille Santus · 2020 · Journal of Clinical Medicine
  43. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study
    Peng Xu, Rong Hua Tian, Song Jiao Luo, Ziyue Zu, Bin Fan, Xi Ming Wang, Kai Lin Xu, Jiang Tao Wang, Juan Zhu, Ji Chan Shi et al. · 2020 · Theranostics
  44. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia
    Jia Li, Xue He, Yuan Yuan, Wei Zhang, Xue Li, Yuhua Zhang, Shaoxiang Li, Chunyan Guan, Zifen Gao, Gehong Dong · 2020 · American Journal of Infection Control
  45. Role of computed tomography in COVID-19
    Gianluca Pontone, Stefano Scafuri, Maria Elisabetta Mancini, Cecilia Agalbato, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Daniele Andreini, Saima Mushtaq et al. · 2020 · Journal of cardiovascular computed tomography
  46. Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial
    Xiao Tang, Yingmei Feng, Ji-Xiang Ni, Jia-Ying Zhang, Li-Min Liu, Ke Hu, Xiu‐Zhi Wu, Ji-Xian Zhang, Jun-Wen Chen, Jian-Chu Zhang et al. · 2021 · Respiration
  47. Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review
    Kuo‐Tung Tang, Bo‐Chueh Hsu, Der‐Yuan Chen · 2021 · Frontiers in Immunology
  48. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication
    Peili Hou, Xuefeng Wang, Hongmei Wang, Tiecheng Wang, Zhangping Yu, Chunqing Xu, Yudong Zhao, Wenqi Wang, Yong Bo Zhao, Fengyun Chu et al. · 2022 · Autophagy
  49. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
    Ruklanthi de Alwis, Shiwei Chen, Esther Shuyi Gan, Eng Eong Ooi · 2020 · EBioMedicine
  50. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients
    Wenjing Wang, Bin Su, Lijun Pang, Luxin Qiao, Yingmei Feng, Yabo Ouyang, Xianghua Guo, Hongbo Shi, Feili Wei, Xiaogang Su et al. · 2020 · Cellular and Molecular Immunology
  51. Sympathetic activation: a potential link between comorbidities and COVID‐19
    Andrea Porzionato, Aron Emmi, Silvia Barbon, Rafael Boscolo-berto A, Carla Stecco, Elena Stocco, Veronica Macchi, Raffaele De · 2020 · FEBS Journal
  52. Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report
    Jairo Corchuelo Ojeda, Francisco Chavier Ulloa · 2020 · International Journal of Infectious Diseases
  53. Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy
    Marco Mirani, Giuseppe Favacchio, Flaminia Carrone, Nazarena Betella, Emilia Biamonte, Emanuela Morenghi, Gherardo Mazziotti, Andrea Gerardo Lania · 2020 · Diabetes Care
  54. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
    Darrell O. Ricke · 2021 · Frontiers in Immunology
  55. Neurological complications and infection mechanism of SARS-CoV-2
    Dandan Wan, Tingfu Du, Weiqi Hong, Li Chen, Haiying Que, Shuaiyao Lu, Xiaozhong Peng · 2021 · Signal Transduction and Targeted Therapy
  56. Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
    Saborni Chakraborty, Joseph C. González, Benjamin Louis Sievers, Vamsee V. A. Mallajosyula, Srijoni Chakraborty, Megha Dubey, Usama Ashraf, Bowie Yik-Ling Cheng, Nimish D. Kathale, Kim Q.T. Tran et al. · 2022 · Science Translational Medicine
  57. Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019
    Guoxin Zhang, Shuke Nie, Zhaohui Zhang, Zhentao Zhang · 2020 · The Journal of Infectious Diseases
  58. Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review)
    George Mihai Nițulescu, Horia Păunescu, Sterghios Athanasios Moschos, Dimitrios Petrakis, Georgiana Nițulescu, Daniel Ion, Demetrios A. Spandidos, Τaxiarchis Κonstantinos Νikolouzakis, Nikolaos Drakoulis, Aristidis Michael Tsatsakis · 2020 · International Journal of Molecular Medicine
  59. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication
    Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah, Chandani Sen, Arunima Purkayastha, Donald B. Kohn, Mark S. Parcells, Sebastian Beck, Heeyoung Kim, Malina A. Bakowski et al. · 2021 · Cell Reports
  60. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
    Ritesh Gupta, Anoop Misra · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  61. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019
    Yong‐Jian Geng, Zhi-Yao Wei, Hai‐Yan Qian, Ji Huang, Robert F. Lodato, Richard J. Castriotta · 2020 · Cardiovascular Pathology
  62. COVID-19 no estado do Ceará, Brasil: comportamentos e crenças na chegada da pandemia
    Danilo Lopes Ferreira Lima, Aldo Angelim Dias, Renata Sabóia Rabelo, Igor Demes da Cruz, Samuel Carvalho Costa, Flávia Maria Noronha Nigri, Jiovanne Rabelo Neri · 2020 · Ciência & Saúde Coletiva
  63. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
    Srinivasa Reddy Bonam, Srini V. Kaveri, Anavaj Sakuntabhai, Laurent Gilardin, Jagadeesh Bayry · 2020 · Cell Reports Medicine
  64. Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease
    Asmaa I. Owis, Marwa S. El-Hawary, Dalia El Amir, Omar M. Aly, Usama Ramadan Abdelmohsen, Mohamed Salah Kamel · 2020 · RSC Advances
  65. Infectivity of human coronavirus in the brain
    Qi Cheng, Yue Yang, Jianqun Gao · 2020 · EBioMedicine
  66. Approach to Acute Cardiovascular Complications in COVID-19 Infection
    Lauren Sharan Ranard, J. Fried, Marwah Abdalla, D. Edmund Anstey, Raymond C. Givens, Deepa Kumaraiah, Susheel Kodali, Koji Takeda, Dimitrios I. Karmpaliotis, LeRoy E. Rabbani et al. · 2020 · Circulation Heart Failure
  67. SARS-CoV-2 Infection–Associated Hemophagocytic Lymphohistiocytosis
    Andrey Prilutskiy, Michael A. Kritselis, Artem Shevtsov, Ilyas Yambayev, Charitha Vadlamudi, Qing Zhao, Yachana Kataria, Shayna Sarosiek, Adam Lerner, John Mark Sloan et al. · 2020 · American Journal of Clinical Pathology
  68. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis
    Yanyan Wu, Hongyu Li, Xiaozhong Guo, Eric M. Yoshida, Nahúm Méndez‐Sánchez, Giovanni Battista Levi Sandri, Rolf Teschke, Fernando Gomes Romeiro, Akash Shukla, Xingshun Qi · 2020 · Hepatology International
  69. COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
    Abdur Rauf, Tareq Abu‐Izneid, Ahmed Olatunde, Anees Ahmed Khalil, Fahad Abdulrahman Alhumaydhi, Tabussam Tufail, Mohammad Ali Shariati, Максим Борисович Ребезов, Zainab M. Almarhoon, Yahia N. Mabkhot et al. · 2020 · International Journal of Environmental Research and Public Health
  70. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
    Balasubramanian Ganesh, Thangarasu Rajakumar, Malathi Mathiyazhakan, Manikandan Natesan, Nagaraj Jaganathasamy, Santhakumar Aridoss, Elangovan Arumugam, Yashpal Singh Malik · 2021 · Clinical Epidemiology and Global Health
  71. Cancer associates with risk and severe events of <scp>COVID</scp> ‐19: A systematic review and meta‐analysis
    Tian, Yehong, Qiu, Xiaowei, Wang, Chengxiang, Zhao, Jianxin, Jiang, Xin, Niu, Wenquan, Huang, Jinchang, Zhang, Fengyu · 2021 · International Journal of Cancer
  72. COVID-19: the need for continuous medical education and training
    Li Li, Qiang-hong Xv, Jing Yan · 2020 · The Lancet Respiratory Medicine
  73. Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia
    Yanlei Li, Yanbing Hu, Jinyan Yu, Tiangang Ma · 2020 · Laboratory Investigation
  74. COVID-19 with cystic features on computed tomography
    Kefu Liu, Yuanying Zeng, Ping Xie, Xun Ye, Guidong Xu, Jian Liu, Hao Wang, Jin-Xian Qian · 2020 · Medicine
  75. Melatonin potentials against viral infections including COVID-19: Current evidence and new findings
    Kobra Bahrampour Juybari, Mohammad Hossein Pourhanifeh, Azam Hosseinzadeh, Karim Hemati, Saeed Mehrzadi · 2020 · Virus Research
  76. Spatiotemporal variations and reduction of air pollutants during the COVID-19 pandemic in a megacity of Yangtze River Delta in China
    Qi Yuan, Bing Qi, Deyun Hu, Junjiao Wang, Jian Zhang, Huanqiang Yang, Shanshan Zhang, Lei Liu, Liang Xu, Weijun Li · 2020 · The Science of The Total Environment
  77. Perceived Control Buffers the Effects of the COVID‐19 Pandemic on General Health and Life Satisfaction: The Mediating Role of Psychological Distance
    Lei Zheng, Miao Miao, Yiqun Gan · 2020 · Applied Psychology Health and Well-Being
  78. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
    Linda Petrone, Elisa Petruccioli, Valentina Vanini, Gilda Cuzzi, Saeid Najafi Fard, Tonino Alonzi, Concetta Castilletti, Fabrizio Palmieri, Gina Gualano, Pietro Vittozzi et al. · 2020 · Clinical Microbiology and Infection
  79. Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
    Farzan Vahedifard, Krishnan V Chakravarthy · 2021 · Emergent Materials
  80. Personal protective equipment (PPE) pollution driven by the COVID-19 pandemic in Cox's Bazar, the longest natural beach in the world
    Md. Refat Jahan Rakib, Gabriel Enrique De-la-Torre, Carlos Ivan Pizarro-Ortega, Diana Carolina Dioses-Salinas, Sultan Al Nahian · 2021 · Marine Pollution Bulletin
  81. T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses
    Elahe Aleebrahim‐Dehkordi, Bahareh Molavi, Melika Mokhtari, Niloofar Deravi, Mobina Fathi, Tara Fazel, Mehdi Mohebalizadeh, Pooneh Koochaki, Parnian Shobeiri, Ali Hasanpour Dehkordi · 2021 · Transplant Immunology
  82. A humanized mouse model of chronic COVID-19
    Esen Sefik, Benjamin Israelow, Haris Mirza, Jun Zhao, Rihao Qu, Eleanna Kaffe, Eric Song, Stephanie Halene, Eric Meffre, Yuval Kluger et al. · 2021 · Nature Biotechnology
  83. Gastrointestinal and Liver Manifestations of COVID-19
    Amol Agarwal, Alan Chen, Nishal Ravindran, Chau To, Paul Joseph Thuluvath · 2020 · Journal of Clinical and Experimental Hepatology
  84. Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists
    Maximilian F. Konig, Michael A. Powell, Verena Staedtke, Ren-Yuan Bai, David L. Thomas, Nicole Mercado Fischer, Sakibul Huq, Adham M. Khalafallah, Allison Koenecke, Ruoxuan Xiong et al. · 2020 · Journal of Clinical Investigation
  85. Hepatic complications of COVID‐19 and its treatment
    Dandan Tian, Qing Ye · 2020 · Journal of Medical Virology
  86. The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
    Kirill Gorshkov, Catherine Z. Chen, Robert J. Bostwick, Lynn A. Rasmussen, Bruce Nguyen Tran, Yu-Shan Cheng, Miao Xu, Manisha Pradhan, Mark J. Henderson, Wei Zhu et al. · 2020 · ACS Infectious Diseases
  87. Endothelial Dysfunction in Covid-19 Infection
    Hassan M. Otifi, Balkur Krishna Moorthy Adiga · 2022 · The American Journal of the Medical Sciences
  88. Air transportation, population density and temperature predict the spread of COVID-19 in Brazil
    Pedro Aurélio Costa Lima Pequeno, Bruna Mendel, Clarissa Rosa, Mariane Bosholn, Jorge Luiz Pereira Souza, Fabrício Beggiato Baccaro, Reinaldo Imbrózio Barbosa, William Ernest Magnusson · 2020 · PeerJ
  89. Coronavirus disease 2019 and cardiovascular system: A narrative review
    Felix Kwenandar, Karunia Valeriani Japar, Vika Damay, Timotius Ivan Hariyanto, Michael S. Tanaka, Nata Pratama Hardjo Lugito, Andree Kurniawan · 2020 · IJC Heart & Vasculature
  90. COVID-19 Sepsis and Microcirculation Dysfunction
    A. Colantuoni, Romeo Martini M. D, Patrizia Caprari, Marco Ballestri, Pier Leopoldo Capecchi, Agostino Gnasso, Rosalia Lo Presti, Antonella Marcoccia, Marco Rossi, Gregorio Caimi · 2020 · Frontiers in Physiology
  91. Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis
    Ting Wu, Zhihong Zuo, Shuntong Kang, Liping Jiang, Xuan Luo, Zanxian Xia, Jing Liu, Xiaojuan Xiao, Mao Ye, Meichun Deng · 2020 · Aging and Disease
  92. Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in”
    Vanessa Castelli, Annamaria Cimini, Claudio Ferri · 2020 · Frontiers in Immunology
  93. Fatal Lymphocytic Cardiac Damage in Coronavirus Disease 2019 (COVID-19): Autopsy Reveals a Ferroptosis Signature
    Werner Jacobs, Martin M. Y. Lammens, Annelies Kerckhofs, Evy Voets, Emily Van San, Samya Van Coillie, Cédric Peleman, Matthias Mergeay, Sabriya Sirimsi, Veerle Matheeussen et al. · 2020 · ESC Heart Failure
  94. COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?
    Joost Boeckmans, Robim Marcelino Rodrigues, Thomas Demuyser, Denis Piérard, Tamara Vanhaecke, Vera Rogiers · 2020 · Archives of Toxicology
  95. Identification of Kidney Transplant Recipients with Coronavirus Disease 2019
    Hui Zhang, Yan Chen, Quan Yuan, Qiu-Xiang Xia, Xian-Peng Zeng, Jing-Tao Peng, Jing Liu, Xingyuan Xiao, Guo-Song Jiang, Han-Yu Xiao et al. · 2020 · European Urology
  96. Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia
    Claudia Große, A Große, Helmut J.F. Salzer, Martin W. Dünser, Reinhard Motz, Rupert Langer · 2020 · Cardiovascular Pathology
  97. A novel artificial intelligence-assisted triage tool to aid in the diagnosis of suspected COVID-19 pneumonia cases in fever clinics
    Cong Feng, Lili Wang, Xin Chen, Yongzhi Zhai, Feng Zhu, Chen Hua, Yingchan Wang, Xiangzheng Su, Sai Huang, Lin Hai Tian et al. · 2021 · Annals of Translational Medicine
  98. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
    Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, Nasrin Amiri Dashatan, Mehdi Koushki, Mohadeseh Nemati, Fahima Danesh Pouya, Mostafa Rezaei–Tavirani, Yousef Rasmi, Lobat Tayebi · 2021 · Biomedicine & Pharmacotherapy
  99. SARS-CoV-2 triggering autoimmune diseases
    Leila Mobasheri, Mohammad Hossein Nasirpour, Elham Masoumi, Afsaneh Foolady Azarnaminy, Mozhdeh Jafari, Seyed‐Alireza Esmaeili · 2022 · Cytokine
  100. Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19
    Cheng, Jinyu, Zhang, Ji, Wu, Zhongdao, Sun, Xiaoqiang · 2021 · Briefings in Bioinformatics